AstraZeneca signs AI research deal with China's CSPC for chronic diseases - Reuters
AstraZeneca has signed an AI -led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the ...
Read the original at Reuters ↗
- Topics
- China & GeopoliticsHealthcare
- Mentions
- China
- Tracked via
- “china ai”